Inimmune develops TLR7/8 agonist for monotherapy or combination with anti-PD-1 therapy May 12, 2022 No Comments
Ichnos selects trispecific antibody ISB-2001 for development in multiple myeloma May 10, 2022 No Comments
iBio presents preclinical data on monoclonal antibody candidate IBIO-101 for solid tumors May 10, 2022 No Comments
AGEN-1571 reverses ILT-2-mediated immunosuppression to activate antitumor immunity May 9, 2022 No Comments
Mosaic signs license agreement covering use of cowpea mosaic virus to treat cancer May 6, 2022 No Comments
Turning Point and LaNova enter license agreement for LM-302 and collaboration on ADC programs May 6, 2022 No Comments
ProfoundBio antibody-drug conjugate PRO-1102 shows potency in vitro and in vivo May 3, 2022 No Comments
Gilead and Dragonfly collaborate to advance NK cell engager-based immunotherapies May 3, 2022 No Comments
RSS